Comparing the current results to its competitors, Orasure Technologies Inc reported Revenue decrease in the 2 quarter 2026 year on year by -1.93 %, despite the revenue increase by the most of its competitors of 10.27 %, recorded in the same quarter.
Orasure Technologies Inc's Comment on Competition and Industry Peers
The diagnostic industry is a multi-billion dollar global market with intense competition. Many competitors are larger and possess greater financial, research, manufacturing, and marketing resources. The Company operates effectively in select market segments by offering rapid tests with proprietary features and emphasizes ease of use, particularly for self-testing. Key competitive factors include price, quality, performance, ease of use, customer service, reputation, scientific and technological capability, proprietary knowledge, regulatory approvals, manufacturing capacity, commercial execution, distribution strength, access to capital, personnel retention, and patent protection. Competition is expected to increase due to technological advancements and new product introductions, which may render existing products obsolete or less competitive. There is no assurance that competitors will not develop superior technologies or obtain regulatory approvals before the Company, which could adversely affect the Company's business and financial condition.
Danaher Corporation operates a diversified business model centered on developing advanced technologies and solutions across multiple sectors, particularly life sciences, diagnostics, dental, and environmental. The company emphasizes continuous innovation and operational excellence, leveraging its proprietary technologies to drive growth and improve efficiency. By strategically acquiring and integrating complementary businesses, Danaher enhances its product offerings while expanding its global market presence.
Boston Scientific Corporations business model centers on creating innovative medical devices for diverse specialties, aimed at addressing unmet medical needs and enhancing patient outcomes. The company sells its products to healthcare professionals and hospitals globally, supported by robust sales and distribution networks. It prioritizes research and development to continually introduce new technologies and solutions.
Bluejay Diagnostics Inc follows a business model where they develop and manufacture diagnostic tests and medical devices for a variety of health conditions, aiming to provide accurate and efficient solutions to healthcare professionals and patients. They primarily operate by selling their products to hospitals, clinics, and other medical institutions.
Becton Dickinson and Company operates a business model focused on developing and providing advanced medical technologies, including a diverse portfolio of medical devices and diagnostic products. Their strategy emphasizes innovation, quality, and strategic partnerships to enhance patient care and streamline healthcare processes across various settings.
Allurion Technologies Inc is a medical device company that specializes in developing non-surgical solutions for weight loss. Their business model is centered around providing a comprehensive weight loss program that combines their innovative medical device, the Elipse Balloon, with personalized coaching and support. They target individuals seeking a non-invasive and convenient approach to achieving their weight loss goals.
Sources:
Orasure Technologies Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Orasure Technologies Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
